Christopher G. Rowe - Concepedia

Author

Christopher G. Rowe

National Institutes of Health ORCID

Also Known As

Chris G. Rowe, Chris Rowe, Christopher G. Rowe, Christopher Rowe

Publications

502

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Institute of Allergy and Infectious Diseases

About

Christopher G. Rowe is an author at National Institutes of Health specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	296
2	Engineering	2	2	122
3	Natural Sciences	1	1	67
4	Biochemistry	1	1	21
5	Biology	1	1	67

Christopher G. Rowe

Publications

413

Citations

H-Index

Page 1

	Year	Citations
Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle Richard L. Shimp, Christopher G. Rowe, Karine Reiter, Vaccine VaccinationNanomedicineNanoparticlesEngineeringNanomaterials	2013	101
The identification of markers segregating with resistance to <i>Schistosoma mansoni</i> infection in the snail <i>Biomphalaria glabrata</i> Matty Knight, André Miller, Carolyn N. Patterson, Proceedings of the National Academy of Sciences Parasitic DiseaseMolecular MarkersGeneticsMolecular GeneticsDna Sequences	1999	67
Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230 Puthupparampil V. Scaria, Christopher G. Rowe, Beth B. Chen, npj Vaccines	2019	51
Antigenicity of infectious pancreatic necrosis virus VP2 subviral particles expressed in yeast F. C. Thomas Allnutt, Robert M. Bowers, Christopher G. Rowe, Vaccine Virus StructureMolecular VirologyPathogenesisImmunologyViral Pathogenesis	2007	50
Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity Puthupparampil V. Scaria, Beth Chen, Christopher G. Rowe, PLoS ONE	2017	39
Expression of a foreign epitope on infectious pancreatic necrosis virus VP2 capsid protein subviral particle (SVP) and immunogenicity in rainbow trout Arun K. Dhar, Robert M. Bowers, Christopher G. Rowe, Antiviral Research Rainbow TroutMolecular VirologyPathogenesisViral PathogenesisImmunology	2010	35
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response Puthupparampil V. Scaria, Nicole Roth, Kim Schwendt, npj Vaccines	2024	27
Comparison of carrier proteins to conjugate malaria transmission blocking vaccine antigens, Pfs25 and Pfs230 Puthupparampil V. Scaria, Beth B. Chen, Christopher G. Rowe, Vaccine VaccinationVaccine DevelopmentVaccine AntigensMedicineVaccine Target	2020	22
A Method for Producing Protein Nanoparticles with Applications in Vaccines D. Stephen Charnock‐Jones, Christopher G. Rowe, Beth Chen, PLoS ONE NanoparticlesComponent ParticlesEngineeringImmunologyBiomedical Engineering	2016	21

Page 1